Supervised injection facilities in Canada: past, present, and future

Area of Science:

• Public Health
• Harm Reduction
• Addiction Studies

Background:

• Canada has historically faced significant health and social harms linked to injection drug use.
• The mid-1990s HIV and overdose epidemics in Vancouver spurred advocacy for supervised injection facilities (SIFs).

Observation:

• Canada's first sanctioned SIF opened in 2003, demonstrating success in reducing drug-related harms.
• Preserving SIFs and driving innovation required sustained activism from people who inject drugs (PWID) and healthcare providers.
• Growing acceptance and overdose concerns have led to a rapid increase in SIF establishment across Canadian cities.

Findings:

• While progress has been made, federal legislation requires amendment to create a more supportive environment for SIFs.
• Continued innovation is crucial, including SIFs for assisted injecting and drug inhalation.
• Developing peer-run, mobile, and hospital-based SIFs are essential next steps to maximize harm reduction impact.

Implications:

• Policy changes are needed to fully support and expand supervised injection services.
• Innovative SIF models can address diverse needs and improve public health outcomes.
• Enhanced SIF accessibility and programming are vital for effective drug harm reduction strategies.